PLC-beta1 knockout mice as a model of disrupted cortical development and plasticity: behavioral endophenotypes and dysregulation of RGS4 gene expression.
The complexity of the genetics underlying schizophrenia is highlighted by the multitude of molecular pathways that have been reported to be disrupted in the disorder including muscarinic, serotonergic, and glutamatergic signaling systems. It is of interest, therefore, that phospholipase C-beta1 (PLC-beta1) acts as a point of convergence for these pathways during cortical development and plasticity. These signaling pathways, furthermore, are susceptible to modulation by RGS4, one of the more promising candidate genes for schizophrenia. PLC-beta1 knockout mice were behaviorally assessed on tests including fear conditioning, elevated plus maze, and the Y maze. In situ hybridization was used to assess RGS4 expression. We found that PLC-beta1 knockout mice display abnormal anxiety profiles on some, but not all measures assessed, including decreased anxiety on the elevated plus maze. We also show memory impairment and a complete absence of acquisition of hippocampal-dependent fear conditioning. Furthermore, at a molecular level, we demonstrate dramatic changes in expression of RGS4 mRNA in selective regions of the PLC-beta1 knockout mouse brain, particularly the CA1 region of the hippocampus. These results validate the utility of the PLC-beta1 knockout mouse as a model of schizophrenia, including molecular and cellular evidence for disrupted cortical maturation and associated behavioral endophenotypes.
McOmish
Caitlin E
CE
Howard Florey Institute, University of Melbourne, Parkville, Victoria, Australia. caitlin.mcomish@florey.edu.au
Burrows
Emma L
EL
Howard
Monique
M
Hannan
Anthony J
AJ
D000818:Animals; D001007:Anxiety / Q000503:physiopathology; D001483:Base Sequence; D001522:Behavior, Animal / Q000502:physiology; D002540:Cerebral Cortex / Q000254:growth & development* / Q000502:physiology*; D003213:Conditioning, Psychological / Q000502:physiology; D017931:DNA Primers / Q000235:genetics; D005239:Fear / Q000502:physiology; D005260:Female; D005786:Gene Expression Regulation; D006624:Hippocampus / Q000502:physiology; D006801:Humans; D008297:Male; D018782:Maze Learning / Q000502:physiology; D008568:Memory / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010641:Phenotype; D054799:Phospholipase C beta / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D020710:RGS Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012559:Schizophrenia / Q000209:etiology / Q000235:genetics / Q000503:physiopathology; D017603:Signal Detection, Psychological
D017931:DNA Primers; D020710:RGS Proteins; D012333:RNA, Messenger; C098799:RGS4 protein; D054799:Phospholipase C beta; C518034:Plcb1 protein, mouse